SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-109411
Filing Date
2023-10-16
Accepted
2023-10-16 17:15:16
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2328366d1_sc13g.htm SC 13G 84853
2 EXHIBIT 99.1 tm2328366d1_ex99-1.htm EX-99.1 6162
  Complete submission text file 0001104659-23-109411.txt   92629
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Subject) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91585 | Film No.: 231327929
SIC: 2834 Pharmaceutical Preparations